info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Portable Diagnostic Devices Companies

Portable diagnostic devices play a critical role in healthcare by providing medical professionals with convenient and rapid means to diagnose, monitor, and manage patients' health conditions. These devices are often compact, user-friendly, and capable of delivering quick results.

Portable Diagnostic Devices Key Companies*Disclaimer: List of key companies in no particular orderLatest Portable diagnostic devices Companies Update



  • Oct 2023: A joint venture and licensing agreement has been announced by Roche and Monte Rosa Therapeutics to develop and discover molecular glue degraders (MGDs) to treat neurological and cancerous illnesses. The collaboration aims to bring together Roche's experience in patient treatment and Monte Rosa's QuEENT discovery engine. The upfront payment to Monte Rosa is $50 million. Based on preclinical, clinical, commercial, and sales milestones, the company may receive future payments surpassing $2 billion in addition to tiered royalties. The parties also expanded their cooperation in the initial two years to include more targets. Instead of tiered royalties on the resulting drugs, further payments will be given for nominations and reaching preclinical, clinical, commercial, and sales milestones. Monte Rosa will oversee preclinical and discovery research against certain cancer and neurological disorders.




  • Aug 2023: A new partnership to address health disparities and lower the risk of heart attacks and strokes in underprivileged Detroit communities was announced today by OMRON Healthcare, a pioneer in global heart health, and EPIC Health, Detroit's healthcare system dedicated to community-focused healthcare. Program participants will have access to VitalSightTM, OMRON's inaugural remote patient monitoring service created exclusively for people with uncontrolled Stage 2 hypertension and other high blood pressure patients. Physicians can provide individuals with elevated hypertension levels with an easy-to-use remote monitoring program called VitalSight. Uncontrolled Stage 2 hypertension affects around 37 million adults in the United States1. If therapy is not received, this condition could raise the danger of heart attacks and strokes, which could cause damage to the arteries and other organs.


List of Portable diagnostic devices Key companies in the market

  • Hoffmann-La Roche Ltd

  • GE Healthcare

  • Medtronic

  • Omron Healthcare Inc.

  • Koninklijke Philips N.V.

  • Abbott

  • COM

  • Stryker

  • Wellue

  • EMAY

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.